In Type 2 Diabetes Mellitus, obesity, extreme insulin resistance, hyperglycemic symptoms

• A first line drug for type II diabetes mellitus with a long term safety profile
• Secondary failure to monotherapy and an initiation therapy in patients with marked hyperglycemia
• Weight neutral combination, thus can be given to obese patients as well